The NSCLC with PIAS1-RASGRF1 was a squamous cell carcinoma, while HSPA4-RASGRF2 was identified in a large cell neuroendocrine carcinoma of the lung. Here, RASGRF1 is linked to non-small cell lung carcinoma.